Symmetry Partners LLC Has $7.60 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Symmetry Partners LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,803 shares of the healthcare conglomerate’s stock after selling 457 shares during the quarter. Symmetry Partners LLC’s holdings in UnitedHealth Group were worth $7,603,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. RBA Wealth Management LLC raised its stake in shares of UnitedHealth Group by 1.2% in the 2nd quarter. RBA Wealth Management LLC now owns 11,488 shares of the healthcare conglomerate’s stock valued at $5,900,000 after purchasing an additional 131 shares during the period. Salvus Wealth Management LLC raised its stake in shares of UnitedHealth Group by 4.9% in the 2nd quarter. Salvus Wealth Management LLC now owns 820 shares of the healthcare conglomerate’s stock valued at $421,000 after purchasing an additional 38 shares during the period. Capital Market Strategies LLC increased its position in shares of UnitedHealth Group by 4.9% in the second quarter. Capital Market Strategies LLC now owns 2,127 shares of the healthcare conglomerate’s stock valued at $1,092,000 after acquiring an additional 100 shares during the last quarter. Thrive Wealth Management LLC increased its position in shares of UnitedHealth Group by 8.6% in the second quarter. Thrive Wealth Management LLC now owns 1,166 shares of the healthcare conglomerate’s stock valued at $599,000 after acquiring an additional 92 shares during the last quarter. Finally, State of Alaska Department of Revenue increased its position in shares of UnitedHealth Group by 3.0% in the second quarter. State of Alaska Department of Revenue now owns 144,947 shares of the healthcare conglomerate’s stock valued at $74,447,000 after acquiring an additional 4,197 shares during the last quarter. Institutional investors and hedge funds own 87.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on UNH. Oppenheimer lifted their target price on UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 25th. Morgan Stanley lifted their price target on UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a report on Thursday, September 8th. Finally, Argus lifted their price target on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a report on Monday, July 25th. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $585.65.

UnitedHealth Group Trading Down 0.4 %

Shares of UNH stock opened at $521.02 on Monday. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60. The stock has a market cap of $487.35 billion, a P/E ratio of 27.21, a price-to-earnings-growth ratio of 1.63 and a beta of 0.76. The stock has a 50 day simple moving average of $529.29 and a 200 day simple moving average of $511.81. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm’s revenue for the quarter was up 12.6% compared to the same quarter last year. During the same period in the previous year, the company posted $4.70 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th will be given a dividend of $1.65 per share. The ex-dividend date of this dividend is Friday, September 9th. This represents a $6.60 annualized dividend and a yield of 1.27%. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,273 shares of the company’s stock in a transaction on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the transaction, the executive vice president now owns 8,104 shares of the company’s stock, valued at $4,043,896. The disclosure for this sale can be found here. Insiders sold a total of 140,324 shares of company stock worth $75,086,185 over the last three months. Corporate insiders own 0.40% of the company’s stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.